Mien-Chie Hung

Mien-Chie Hung

China Medical University, Taiwan
在 cmu.edu.tw 的电子邮件经过验证
被引用次数：109393
Immunotherapy Target Therapy Cross talk and Drug Resistance Breast and GI Cancers
Sabrina Pricl

Sabrina Pricl

University of Trieste
在 di3.units.it 的电子邮件经过验证
被引用次数：13734
Nanotechnology engineering target therapy cancer molecular biology
Jinfang Zhang

Jinfang Zhang

Instructor, Beth Israel Deaconess Medical Center, Harvard Medical School
在 bidmc.harvard.edu 的电子邮件经过验证
被引用次数：8558
Cancer immunotherapy Target therapy Cell cycle E3 ligase PETN-Akt pathway
Feng Zhu

Feng Zhu

Director, Cancer Research Institute. Guilin Medical University. PR China
在 hust.edu.cn 的电子邮件经过验证
被引用次数：4719
Target Therapy Novel onco-kinase Signal Transduction Drug resistance.
Serena Marchiò

Serena Marchiò

Department of Oncology, University of Turin School of Medicine, Candiolo, Italy
在 unito.it 的电子邮件经过验证
被引用次数：3209
Phage Display Biotechnology Target Therapy Ligand-directed Imaging Tumor Microenvironment
Serena Marchio'

Serena Marchio'

University of Turin
在 unito.it 的电子邮件经过验证
被引用次数：3209
phage display oncology target therapy nanotechnology
Simone Di Franco

Simone Di Franco

University of Palermo, MEPRECC
在 unipa.it 的电子邮件经过验证
被引用次数：2643
Cancer biology cancer immunology cell death target therapy.
Jilong Yang, M.D., Ph.D.（杨吉龙）

Jilong Yang, MD, Ph.D.（杨吉龙）

Tianjin Medical University Cancer Hospital & Institute
在 tjmuch.com 的电子邮件经过验证
被引用次数：2638
Sarcoma Oncology Genomics Target therapy Surgery
Hailiang Hu

Hailiang Hu

SUSTech
在 sustech.edu.cn 的电子邮件经过验证
被引用次数：2422
Tumor metabolism DNA repair target therapy
YI-HSIN Hsu

YI-HSIN Hsu

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson …
在 mdanderson.org 的电子邮件经过验证
被引用次数：2122
Phase 1 clinical trial TNBC Target therapy breast cancer bioinformatics
1 - 10